Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

One More Hurricane, One More Lesson Not Learned.

Mann PA.

J Appl Lab Med. 2019 Sep;4(2):290-292. doi: 10.1373/jalm.2018.028738. No abstract available.

PMID:
31639679
2.

Inhibitor of intramembrane protease RseP blocks the σE response causing lethal accumulation of unfolded outer membrane proteins.

Konovalova A, Grabowicz M, Balibar CJ, Malinverni JC, Painter RE, Riley D, Mann PA, Wang H, Garlisi CG, Sherborne B, Rigel NW, Ricci DP, Black TA, Roemer T, Silhavy TJ, Walker SS.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6614-E6621. doi: 10.1073/pnas.1806107115. Epub 2018 Jun 25.

3.

Data documenting the performance of the PT/INR line correction method for reconciling INR discrepancies between central laboratory coagulation analyzers using different thromboplastins during the evaluation of a portable Coagulometer.

Baker WS, Albright KJ, Spratt H, Berman M, Mann PA, Unabia J, Petersen JR.

Data Brief. 2017 Nov 7;16:312-320. doi: 10.1016/j.dib.2017.11.020. eCollection 2018 Feb.

4.

POCT PT INR - Is it adequate for patient care? A comparison of the Roche Coaguchek XS vs. Stago Star vs. Siemens BCS in patients routinely seen in an anticoagulation clinic.

Baker WS, Albright KJ, Berman M, Spratt H, Mann PA, Unabia J, Petersen JR.

Clin Chim Acta. 2017 Sep;472:139-145. doi: 10.1016/j.cca.2017.07.027. Epub 2017 Aug 1.

PMID:
28774502
5.

Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.

Wang H, Mann PA, Xiao L, Gill C, Galgoci AM, Howe JA, Villafania A, Barbieri CM, Malinverni JC, Sher X, Mayhood T, McCurry MD, Murgolo N, Flattery A, Mack M, Roemer T.

Cell Chem Biol. 2017 May 18;24(5):576-588.e6. doi: 10.1016/j.chembiol.2017.03.014. Epub 2017 Apr 20.

6.

Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets.

Mann PA, Müller A, Wolff KA, Fischmann T, Wang H, Reed P, Hou Y, Li W, Müller CE, Xiao J, Murgolo N, Sher X, Mayhood T, Sheth PR, Mirza A, Labroli M, Xiao L, McCoy M, Gill CJ, Pinho MG, Schneider T, Roemer T.

PLoS Pathog. 2016 May 4;12(5):e1005585. doi: 10.1371/journal.ppat.1005585. eCollection 2016 May.

7.

Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis.

Mann PA, McLellan CA, Koseoglu S, Si Q, Kuzmin E, Flattery A, Harris G, Sher X, Murgolo N, Wang H, Devito K, de Pedro N, Genilloud O, Kahn JN, Jiang B, Costanzo M, Boone C, Garlisi CG, Lindquist S, Roemer T.

ACS Infect Dis. 2015 Jan 9;1(1):59-72. doi: 10.1021/id5000212. Epub 2014 Dec 12.

8.

Selective small-molecule inhibition of an RNA structural element.

Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T.

Nature. 2015 Oct 29;526(7575):672-7. doi: 10.1038/nature15542. Epub 2015 Sep 30.

PMID:
26416753
9.

Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.

Mann PA, Müller A, Xiao L, Pereira PM, Yang C, Ho Lee S, Wang H, Trzeciak J, Schneeweis J, Dos Santos MM, Murgolo N, She X, Gill C, Balibar CJ, Labroli M, Su J, Flattery A, Sherborne B, Maier R, Tan CM, Black T, Onder K, Kargman S, Monsma FJ Jr, Pinho MG, Schneider T, Roemer T.

ACS Chem Biol. 2013 Nov 15;8(11):2442-51. doi: 10.1021/cb400487f. Epub 2013 Sep 5.

PMID:
23957438
10.

Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1).

McNicholas PM, Mann PA, Wojcik L, Qiu P, Lee E, McCarthy M, Shen J, Black TA, Strizki JM.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):222-9. doi: 10.1097/QAI.0b013e3181ff63ee.

PMID:
21209592
11.

Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.

Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA.

Antimicrob Agents Chemother. 2009 Dec;53(12):5026-34. doi: 10.1128/AAC.01031-09. Epub 2009 Sep 28.

12.

Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae.

Chau AS, Chen G, McNicholas PM, Mann PA.

Antimicrob Agents Chemother. 2006 Nov;50(11):3917-9. Epub 2006 Sep 11.

13.

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.

Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.

Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15.

14.

Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.

Munayyer HK, Mann PA, Chau AS, Yarosh-Tomaine T, Greene JR, Hare RS, Heimark L, Palermo RE, Loebenberg D, McNicholas PM.

Antimicrob Agents Chemother. 2004 Oct;48(10):3690-6.

15.

Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.

Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS.

Antimicrob Agents Chemother. 2003 May;47(5):1719-26.

16.

Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.

Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM.

Antimicrob Agents Chemother. 2003 Feb;47(2):577-81.

17.

EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.

Mann PA, Xiong L, Mankin AS, Chau AS, Mendrick CA, Najarian DJ, Cramer CA, Loebenberg D, Coates E, Murgolo NJ, Aarestrup FM, Goering RV, Black TA, Hare RS, McNicholas PM.

Mol Microbiol. 2001 Sep;41(6):1349-56.

18.

Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin.

McNicholas PM, Mann PA, Najarian DJ, Miesel L, Hare RS, Black TA.

Antimicrob Agents Chemother. 2001 Jan;45(1):79-83.

19.

Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.

McNicholas PM, Najarian DJ, Mann PA, Hesk D, Hare RS, Shaw KJ, Black TA.

Antimicrob Agents Chemother. 2000 May;44(5):1121-6.

20.

Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase.

Rather PN, Mann PA, Mierzwa R, Hare RS, Miller GH, Shaw KJ.

Antimicrob Agents Chemother. 1993 Oct;37(10):2074-9.

21.

Increased biliary transferrin excretion following parenteral aluminium administration to rats.

Klein GL, Goldblum RM, Moslen MT, Pyron DL, Mann PA, Lee TC, Alfrey AC.

Pharmacol Toxicol. 1993 Jun;72(6):373-6.

PMID:
8361948
22.

Urinary retention in a bitch.

Siddorn RH, Mann PA.

Vet Rec. 1993 May 22;132(21):540. No abstract available.

PMID:
8322449
23.

Environmental control. Are you really managing?

Mann PA.

Exec Housekeep Today. 1992 Aug;13(8):12-3. No abstract available.

PMID:
10121280
25.

Effects of aluminum on the liver following high-dose enteral administration to rats.

Klein GL, Lee TC, Mann PA, Miller NL, Alfrey AC.

J Pediatr Gastroenterol Nutr. 1989 Jul;9(1):105-7.

PMID:
2506321
26.

Effect of acute and chronic pentylenetetrazol treatment on benzodiazepine and cholinergic receptor binding in rat brain.

Lal H, Mann PA Jr, Shearman GT, Lippa AS.

Eur J Pharmacol. 1981 Oct 22;75(2-3):115-9.

PMID:
6274662
27.

A model for the rapid induction of barbiturate tolerance.

Mann PA Jr, Isom GE.

Proc West Pharmacol Soc. 1978;21:387-90. No abstract available.

PMID:
693521
28.

Student consultants: evaluations by consultees.

Mann PA.

Am J Community Psychol. 1973 Apr-Jun;1(2):182-93. No abstract available.

PMID:
4790333
29.

Residential mobility as an adaptive experience.

Mann PA.

J Consult Clin Psychol. 1972 Aug;39(1):37-42. No abstract available.

PMID:
5045283
30.

Accessibility and organizational power in the entry phase of mental health consultation.

Mann PA.

J Consult Clin Psychol. 1972 Apr;38(2):215-8. No abstract available.

PMID:
5017778
31.

Establishing a mental health consultation program with a police department.

Mann PA.

Community Ment Health J. 1971 Jun;7(2):118-26. No abstract available.

PMID:
5163641
32.

Effects of anxiety and defensive style on some aspects of friendship.

Mann PA.

J Pers Soc Psychol. 1971 Apr;18(1):55-61. No abstract available.

PMID:
5550435
33.

Validation of an objective measure of achievement motivation.

Carney RE, Mann PA, McCormick RP.

Psychol Rep. 1966 Aug;19(1):243-8. No abstract available.

PMID:
5942093

Supplemental Content

Support Center